Drug Information
Side Effects > Aerospan

Aerospan Side Effects

Please note - some side effects for Aerospan may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).


Side Effects of Aerospan - for the Consumer

Aerospan HFA Inhaler

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Aerospan HFA Inhaler:

Cough; runny nose; sinus inflammation; stomach pain or upset; throat irritation.

Seek medical attention right away if any of these SEVERE side effects occur when using Aerospan HFA Inhaler:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; depression; ear or eye pain or discharge; mental or mood changes; new or worsening breathing problems (eg, shortness of breath, increased wheezing); nosebleeds; severe stomach pain; signs of infection (eg, fever, chills, persistent sore throat); sore mouth; unusual weakness or fatigue; vision changes; white patches in the mouth or throat.

Top

Aerospan Side Effects - for the Professional

Aerospan

The following table shows the adverse reactions that were reported in patients previously receiving bronchodilators and/or orally inhaled corticosteroids in two double-blind, placebo-controlled US clinical studies, in which 519 adult and pediatric patients age 4-78 years (279 males and 240 females) were treated with the Aerospan Inhalation Aerosol (80 mcg to 320 mcg twice daily for 12 weeks) or placebo. The mean duration of exposure was 76.7, 78.2, 80.5, and 69.4 days for Aerospan Inhalation Aerosol 80 mcg, 160 mcg, 320 mcg, and placebo, all dosed twice daily, respectively. The table includes all events (whether considered drug-related or non-drug-related by the investigators) that occurred at a rate of >3% in any Aerospan Inhalation Aerosol group and were more common than in the placebo group. In considering these data, the increased average duration of exposure for Aerospan Inhalation Aerosol patients should be taken into account, compared with placebo-treated patients.

Adverse Events with >3% incidence reported in controlled clinical studies with Aerospan Inhalation Aerosol (% of patients)
ADVERSE EVENT PLACEBO
(n = 220)
Aerospan Inhalation Aerosol
80 MCG
(n = 189)
160 MCG
(n = 217)
320 MCG
(n = 113)
BODY AS A WHOLE
Headache 12.7 9.0 13.8 8.8
Fever 5.0 6.9 3.7 0.9
Allergic Reaction 2.3 4.2 4.6 4.4
Pain 3.6 2.6 4.6 1.8
Accidental Injury 2.3 3.7 3.7 3.5
Infection, Bacterial 0.9 3.7 0.9 0.9
Back Pain 2.3 0.5 3.2 1.8
DIGESTIVE SYSTEM
Vomiting 4.1 4.2 4.6 0.0
Dyspepsia 1.4 2.1 3.2 3.5
RESPIRATORY SYSTEM
Pharyngitis 13.2 17.5 16.6 16.8
Rhinitis 10.0 9.0 15.7 3.5
Cough Increased 7.7 8.5 5.5 1.8
Sinusitis 5.5 7.4 4.1 8.8
Epistaxis 0.9 3.2 0.9 0.0
SKIN AND APPENDAGES
Rash 3.2 2.6 3.7 1.8
UROGENITAL SYSTEM
Urinary Tract Infection 0.5 1.1 0.9 3.5

The following other adverse events occurred in patients in these clinical studies using Aerospan Inhalation Aerosol with an incidence of 1 to 3% and were more common in Aerospan Inhalation Aerosol than in the placebo group.

 
Body As A Whole: abdominal pain, chest pain, infection, neck pain
 
Digestive System: diarrhea, gastroenteritis, nausea, oral moniliasis
 
Metabolic And Nutritional Disorders: edema
 
Musculoskeletal System: myalgia
 
Nervous System: dizziness, insomnia, migraine
 
Respiratory System: bronchitis, laryngitis, voice alteration
 
Skin And Appendages: erythema multiforme
 
Special Senses: conjunctivitis, ear pain, taste perversion
 
Urogenital System: dysmenorrhea, vaginitis

Cases of growth suppression have been reported for orally inhaled corticosteroids

Top

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


MedNotes
Advertisement

(web9)